Carotid Surgery or Stenting Following Neck Irradiation: Time to Address the Assumptions  by Abbott, A.L.
at SciVerse ScienceDirect
European Journal of Vascular and Endovascular Surgery 43 (2012) 8e9Contents lists availableEuropean Journal of Vascular and Endovascular Surgery
journal homepage: www.ejves.comInvited Commentary
Carotid Surgery or Stenting Following Neck Irradiation: Time to Address the
Assumptions
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b Florey Neuroscience Institutes, 245 Burgundy Street, Heidelberg, Victoria 3084, AustraliaMagne et al. are to be congratulated for reviewing the outcomes
of carotid surgery for their 24 patients with prior neck irradiation,1
adding one of the largest and longest followed case-series reported
for such patients. This, and the other 17 case-series quoted by
Magne et al. of patients with prior neck irradiation undergoing
open carotid surgery2e9 or angioplasty/stenting,9e17 illustrate how
these procedures are technically possible with low 30-day proce-
dural stroke/death rates. Considering all 18 case-series, the peri-
procedural 30-day stroke/death rate was 0% in ten
(56%).1,3e6,8,11,12,15,17 However, among these ten case-series, the
average sample size was only 16 patients (range 4e28) with a mean
followup of approximately 1.6 years (range 1e37 months). By
contrast, in the remaining eight case-series, the 30-day perioper-
ative stroke/death rate was >0% (range 1.5e10%). In these, the
average sample size was over double, 35 patients (range 10e135),
with a mean followup of approximately 2.7 years (range 18e58
months). Small sample sizes, brief followup and publication bias
(good operative results more likely reported and published) are
important reasons why routine practice procedural risk may be
underestimated. It has taken prospective studies of thousands of
patients to compare safety of carotid surgery versus stenting in
patients without prior neck irradiation.
Further, it is clear that procedural results from one centre cannot
be assumed equivalent to another. Crucial elements in determining
procedural complication rates are; operator experience, procedural
technique, quality of vascular disease medical (non-invasive)
intervention received, patient risk factor proﬁle and method of
followup to identify outcomes. It is also clear that the stroke
prevention efﬁcacy of vascular disease medical intervention has
improved signiﬁcantly over recent decades indicating that fewer
patients are now likely to beneﬁt from invasive carotid
procedures.18e21 As medical intervention improves, invasive
carotid procedures need to become more specialised. It is time for
all carotid surgery and endovascular services to adopt ongoing
audit activities, documenting use of current, optimal vascular
disease medical intervention and procedural technique and incor-
porating independent, prospective identiﬁcation of outcomes ofDOI of original article: 10.1016/j.ejvs.2011.09.006.
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doi:10.1016/j.ejvs.2011.09.021interest. Inter-centre collaborative activity is required to combine
quality outcome data for minority patient subgroups, such as those
with prior neck irradiation.
Perhaps more important is the likelihood of a stroke prevention
beneﬁt from invasive carotid procedures, particularly in patients
already subjected to therapy for malignancy. Extrapolation has
been made from randomised trials of carotid surgery versus
medical intervention alone for patients with asymptomatic22e25 or
symptomatic carotid stenosis26e28 and without prior neck irradia-
tion. However, best evidence now indicates that even among
‘generally ﬁt’ hospital associated patients with moderate-severe
asymptomatic carotid stenosis, routine carotid surgery is no
longer likely to provide a stroke prevention beneﬁt over current,
optimal medical intervention alone.18,20 Of concern, 22e73% of the
quoted case-series patients had asymptomatic carotid stenosis. In
addition, improvements in medical intervention imply that a 6%
30-day procedural stroke/death rate for patients with symptomatic
carotid stenosis is now too high and needs re-measurement.
Further, it cannot be assumed that patients with prior neck irra-
diation have the same chance of stroke prevention beneﬁt as past
randomised trial patients. In fact, the evidence suggests that irra-
diated patients are less likely to beneﬁt from invasive carotid
procedures. Among the 18 reported case-series, the average annual
all-cause mortality rate was not given in three,4,8,17 was zero in four
(reﬂecting insufﬁcient data)2,6,11,12 or was 2.3e19.7%.1,3,5,7,9,10,13e16
The most common cause of death was malignancy in all except
two small series of nine3 and 16 patients.13 By contrast, the most
common cause of death in the largest prospective studies of
patients with 50e99% carotid stenosis, without prior neck irradi-
ation, has been vascular disease, with an average annual all-cause
mortality rate of 1.7e8.3%.22e24,27e34 (all raw data calculations).
We need ongoing, long-term, prospective, observational data for
patients receiving neck irradiation (whether or not referred to
vascular proceduralists) to determine the incidence, imaging
characteristics, risk of stroke or death and cause of death with
current, optimal vascular disease medical intervention alone. If
subgroups with sufﬁciently high stroke risk are identiﬁed, quality,
audit-derived measurements of procedural outcomes and/or
randomised trials of surgery/endovascular intervention may help
determine routine practice recommendations. Until then, we are
not entitled to assume that invasive carotid procedures are indi-
cated ‘routinely’ for stroke prevention in patients with prior neckd by Elsevier Ltd. All rights reserved.
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surgery or redo-endovascular intervention for asymptomatic
post-procedural stenosis is beneﬁcial without sufﬁcient followup of
patients given current, optimal vascular disease medical interven-
tion alone.
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